{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T06:36:32Z","timestamp":1791182192189,"version":"4.1.0"},"reference-count":230,"publisher":"American Society of Hematology","issue":"4","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2003,2,15]]},"abstract":"<jats:p>Disruption of the physiologic balance between cell proliferation and death is a universal feature of all cancers. In general terms, human B-cell lymphomas can be subdivided into 2 main groups, low- and high-growth fraction lymphomas, according to the mechanisms through which this imbalance is achieved. Most types of low-growth fraction lymphomas are initiated by molecular events resulting in the inhibition of apoptosis, such as translocations affecting BCL2, in follicular lymphoma, or BCL10 and API2\/MLT1, in mucosa-associated lymphoid tissue (MALT) lymphomas. This results in cell accumulation as a consequence of prolonged cell survival. In contrast, high-growth fraction lymphomas are characterized by an enhanced proliferative activity, as a result of the deregulation of oncogenes with cell cycle regulatory functions, such asBCL6, in large B-cell lymphoma, or c-myc, in Burkitt lymphoma. Low- and high-growth fraction lymphomas are both able to accumulate other alterations in cell cycle regulation, most frequently involving tumor suppressor genes such asp16INK4a, p53, andp27KIP1. As a consequence, these tumors behave as highly aggressive lymphomas. The simultaneous inactivation of several of these regulators confers increased aggressivity and proliferative advantage to tumoral cells. In this review we discuss our current knowledge of the alterations in each of these pathways, with special emphasis on the deregulation of cell cycle progression, in an attempt to integrate the available information within a global model that describes the contribution of these molecular changes to the genesis and progression of B-cell lymphomas.<\/jats:p>","DOI":"10.1182\/blood-2002-07-2009","type":"journal-article","created":{"date-parts":[[2003,1,30]],"date-time":"2003-01-30T21:36:12Z","timestamp":1043962572000},"page":"1220-1235","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":264,"title":["Cell cycle deregulation in B-cell lymphomas"],"prefix":"10.1182","volume":"101","author":[{"given":"Margarita","family":"Sa\u0301nchez-Beato","sequence":"first","affiliation":[{"name":"From the Lymphoma Group, Molecular Pathology Program, Centro Nacional de Investigaciones Oncolo\u0301gicas (CNIO), Madrid, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abel","family":"Sa\u0301nchez-Aguilera","sequence":"additional","affiliation":[{"name":"From the Lymphoma Group, Molecular Pathology Program, Centro Nacional de Investigaciones Oncolo\u0301gicas (CNIO), Madrid, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel A.","family":"Piris","sequence":"additional","affiliation":[{"name":"From the Lymphoma Group, Molecular Pathology Program, Centro Nacional de Investigaciones Oncolo\u0301gicas (CNIO), Madrid, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111821490364500_B1","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1056\/NEJM198211113072002","article-title":"Distinctive chromosomal abnormalities in histologic subtypes of non-Hodgkin's lymphoma.","volume":"307","author":"Yunis","year":"1982","journal-title":"N Engl J Med."},{"key":"2019111821490364500_B2","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1126\/science.3874430","article-title":"Involvement of the bcl-2 gene in human follicular lymphoma.","volume":"228","author":"Tsujimoto","year":"1985","journal-title":"Science."},{"key":"2019111821490364500_B3","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0092-8674(86)90362-4","article-title":"Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2\/immunoglobulin transcript resulting from the t(14;18) translocation.","volume":"47","author":"Cleary","year":"1986","journal-title":"Cell."},{"key":"2019111821490364500_B4","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1056\/NEJM198711053171904","article-title":"Molecular analysis of the t(14;18) chromosomal translocation in malignant lymphomas.","volume":"317","author":"Weiss","year":"1987","journal-title":"N Engl J Med."},{"key":"2019111821490364500_B5","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1056\/NEJM198701083160204","article-title":"Multiple recurrent genomic defects in follicular lymphoma: a possible model for cancer.","volume":"316","author":"Yunis","year":"1987","journal-title":"N Engl J Med."},{"key":"2019111821490364500_B6","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1126\/science.6093263","article-title":"Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation.","volume":"226","author":"Tsujimoto","year":"1984","journal-title":"Science."},{"key":"2019111821490364500_B7","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0092-8674(85)80070-2","article-title":"Cloning the chromosomal breakpoint of t(14;18) human lymphomas: clustering around JH on chromosome 14 and near a transcriptional unit on 18.","volume":"41","author":"Bakhshi","year":"1985","journal-title":"Cell."},{"key":"2019111821490364500_B8","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1084\/jem.164.1.315","article-title":"Detection of a second t(14;18) breakpoint cluster region in human follicular lymphomas.","volume":"164","author":"Cleary","year":"1986","journal-title":"J Exp Med."},{"key":"2019111821490364500_B9","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/S0002-9440(10)64905-X","article-title":"High frequency of t(14;18)-translocation breakpoints outside of major breakpoint and minor cluster regions in follicular lymphomas: improved polymerase chain reaction protocols for their detection.","volume":"160","author":"Albinger-Hegyi","year":"2002","journal-title":"Am J Pathol."},{"key":"2019111821490364500_B10","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0092-8674(00)80957-5","article-title":"Bcl10 is involved in t(1;14)(p22;q32) of MALT B cell lymphoma and mutated in multiple tumor types.","volume":"96","author":"Willis","year":"1999","journal-title":"Cell."},{"key":"2019111821490364500_B11","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/8767","article-title":"Inactivating mutations and overexpression of BCL10, a caspase recruitment domain-containing gene, in MALT lymphoma with t(1;14)(p22;q32).","volume":"22","author":"Zhang","year":"1999","journal-title":"Nat Genet."},{"key":"2019111821490364500_B12","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1182\/blood.V74.5.1796.1796","article-title":"Four new recurring translocations in non-Hodgkin lymphoma.","volume":"74","author":"Levine","year":"1989","journal-title":"Blood."},{"key":"2019111821490364500_B13","doi-asserted-by":"crossref","first-page":"3601","DOI":"10.1182\/blood.V93.11.3601","article-title":"The apoptosis inhibitor gene API2 and a novel 18q gene, MLT, are recurrently rearranged in the t(11;18)(q21;q21)p6ssociated with mucosa-associated lymphoid tissue lymphomas.","volume":"93","author":"Dierlamm","year":"1999","journal-title":"Blood."},{"key":"2019111821490364500_B14","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/S0002-9440(10)65012-2","article-title":"The product of the t(11;18), an API2-MLT fusion, marks nearly half of gastric MALT type lymphomas without large cell proliferation.","volume":"156","author":"Baens","year":"2000","journal-title":"Am J Pathol."},{"key":"2019111821490364500_B15","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/1098-2264(2000)9999:9999<::AID-GCC1036>3.0.CO;2-I","article-title":"Structure of the MLT gene and molecular characterization of the genomic breakpoint junctions in the t(11;18)(q21;q21) of marginal zone B-cell lymphomas of MALT type.","volume":"29","author":"Baens","year":"2000","journal-title":"Genes Chromosomes Cancer."},{"key":"2019111821490364500_B16","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0002-9440(10)64012-6","article-title":"API2-MALT1 fusion transcripts involved in mucosa-associated lymphoid tissue lymphoma: multiplex RT-PCR detection using formalin-fixed paraffin-embedded specimens.","volume":"158","author":"Inagaki","year":"2001","journal-title":"Am J Pathol."},{"key":"2019111821490364500_B17","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1182\/blood.V98.4.1182","article-title":"T(11;18)(q21;q21) is associated with advanced mucosa-associated lymphoid tissue lymphoma that expresses nuclear BCL10.","volume":"98","author":"Liu","year":"2001","journal-title":"Blood."},{"key":"2019111821490364500_B18","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/315340a0","article-title":"Clustering of breakpoints on chromosome 11 in human B-cell neoplasms with the t(11;14) chromosome translocation.","volume":"315","author":"Tsujimoto","year":"1985","journal-title":"Nature."},{"key":"2019111821490364500_B19","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1126\/science.6610211","article-title":"Molecular cloning of the chromosomal breakpoint of B-cell lymphomas and leukemias with the t(11;14) chromosome translocation.","volume":"224","author":"Tsujimoto","year":"1984","journal-title":"Science."},{"key":"2019111821490364500_B20","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1182\/blood.V84.8.2726.2726","article-title":"PRAD-1\/cyclin D1 gene overexpression in chronic lymphoproliferative disorders: a highly specific marker of mantle cell lymphoma.","volume":"84","author":"Bosch","year":"1994","journal-title":"Blood."},{"key":"2019111821490364500_B21","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1182\/blood.V88.4.1177.bloodjournal8841177","article-title":"Direct visualization of dispersed 11q13 chromosomal translocations in mantle cell lymphoma by multicolor DNA fiber fluorescence in situ hybridization.","volume":"88","author":"Vaandrager","year":"1996","journal-title":"Blood."},{"key":"2019111821490364500_B22","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1006\/geno.1997.4747","article-title":"Cloning and gene mapping of the chromosome 13q14 region deleted in chronic lymphocytic leukemia.","volume":"42","author":"Kalachikov","year":"1997","journal-title":"Genomics."},{"key":"2019111821490364500_B23","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1182\/blood.V80.10.2594.2594","article-title":"t(9;14)(p13;q32) denotes a subset of low-grade non-Hodgkin's lymphoma with plasmacytoid differentiation.","volume":"80","author":"Offit","year":"1992","journal-title":"Blood."},{"key":"2019111821490364500_B24","doi-asserted-by":"crossref","first-page":"4110","DOI":"10.1182\/blood.V88.11.4110.4110","article-title":"The t(9;14)(p13;q32) chromosomal translocation associated with lymphoplasmacytoid lymphoma involves the PAX-5 gene.","volume":"88","author":"Iida","year":"1996","journal-title":"Blood."},{"key":"2019111821490364500_B25","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1182\/blood.V83.9.2423.2423","article-title":"LAZ3 rearrangements in non-Hodgkin's lymphoma: correlation with histology, immunophenotype, karyotype, and clinical outcome in 217 patients.","volume":"83","author":"Bastard","year":"1994","journal-title":"Blood."},{"key":"2019111821490364500_B26","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1056\/NEJM199407143310202","article-title":"Rearrangement of the bcl-6 gene as a prognostic marker in diffuse large-cell lymphoma.","volume":"331","author":"Offit","year":"1994","journal-title":"N Engl J Med."},{"key":"2019111821490364500_B27","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1182\/blood.V83.7.1757.1757","article-title":"Rearrangements of the BCL6 gene in diffuse large cell non-Hodgkin's lymphoma.","volume":"83","author":"Lo Coco","year":"1994","journal-title":"Blood."},{"key":"2019111821490364500_B28","doi-asserted-by":"crossref","first-page":"5595","DOI":"10.1038\/sj.onc.1204595","article-title":"Translocations involving c-myc and c-myc function.","volume":"20","author":"Boxer","year":"2001","journal-title":"Oncogene."},{"key":"2019111821490364500_B29","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0065-230X(08)60200-6","article-title":"Activation of cellular oncogenes in hemopoietic cells by chromosome translocation.","volume":"47","author":"Cory","year":"1986","journal-title":"Adv Cancer Res."},{"key":"2019111821490364500_B30","doi-asserted-by":"crossref","first-page":"7824","DOI":"10.1073\/pnas.79.24.7824","article-title":"Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells.","volume":"79","author":"Dalla-Favera","year":"1982","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2019111821490364500_B31","doi-asserted-by":"crossref","first-page":"7837","DOI":"10.1073\/pnas.79.24.7837","article-title":"Translocation of the c-myc gene into the immunoglobulin heavy chain locus in human Burkitt lymphoma and murine plasmacytoma cells.","volume":"79","author":"Taub","year":"1982","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2019111821490364500_B32","first-page":"1883","article-title":"Indolent B-cell non-Hodgkin's lymphomas.","volume":"11","author":"Seng","year":"1987","journal-title":"Oncology (Huntingt)."},{"key":"2019111821490364500_B33","first-page":"195","article-title":"Molecular pathophysiology of indolent lymphoma.","volume":"85","author":"Capello","year":"2000","journal-title":"Haematologica."},{"key":"2019111821490364500_B34","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/nrc776","article-title":"Death and anti-death: tumour resistance to apoptosis.","volume":"2","author":"Igney","year":"2002","journal-title":"Nat Rev Cancer."},{"key":"2019111821490364500_B35","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1056\/NEJM198806233182502","article-title":"Expression in non-Hodgkin's lymphoma of the bcl-2 protein associated with the t(14;18) chromosomal translocation.","volume":"318","author":"Ngan","year":"1988","journal-title":"N Engl J Med."},{"key":"2019111821490364500_B36","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1016\/0140-6736(90)93216-C","article-title":"Bcl-2 protein expression in follicular lymphomas in absence of 14;18 translocation.","volume":"336","author":"Pezzella","year":"1990","journal-title":"Lancet."},{"key":"2019111821490364500_B37","first-page":"410","article-title":"BCL2 gene activation and protein expression in follicular lymphoma: a report on 64 cases.","volume":"7","author":"Seite","year":"1993","journal-title":"Leukemia."},{"key":"2019111821490364500_B38","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1182\/blood.V91.1.244","article-title":"Unbalanced expression of Bcl-2 family proteins in follicular lymphoma: contribution of CD40 signaling in promoting survival.","volume":"91","author":"Ghia","year":"1998","journal-title":"Blood."},{"key":"2019111821490364500_B39","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.1182\/blood.V85.9.2528.bloodjournal8592528","article-title":"Lymphoma-associated translocation t(14;18) in blood B cells of normal individuals.","volume":"85","author":"Limpens","year":"1995","journal-title":"Blood."},{"key":"2019111821490364500_B40","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1128\/MCB.10.5.1901","article-title":"Deregulated Bcl-2-immunoglobulin transgene expands a resting but responsive immunoglobulin M and D-expressing B-cell population.","volume":"10","author":"McDonnell","year":"1990","journal-title":"Mol Cell Biol."},{"key":"2019111821490364500_B41","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0092-8674(89)90174-8","article-title":"bcl-2-immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation.","volume":"57","author":"McDonnell","year":"1989","journal-title":"Cell."},{"key":"2019111821490364500_B42","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/349254a0","article-title":"Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14; 18).","volume":"349","author":"McDonnell","year":"1991","journal-title":"Nature."},{"key":"2019111821490364500_B43","doi-asserted-by":"crossref","first-page":"8661","DOI":"10.1073\/pnas.88.19.8661","article-title":"Enforced BCL2 expression in B-lymphoid cells prolongs antibody responses and elicits autoimmune disease.","volume":"88","author":"Strasser","year":"1991","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2019111821490364500_B44","doi-asserted-by":"crossref","first-page":"4677","DOI":"10.1182\/blood.V91.12.4677","article-title":"Homozygous deletions at chromosome 9p21 involving p16 and p15 are associated with histologic progression in follicle center lymphoma.","volume":"91","author":"Elenitoba-Johnson","year":"1998","journal-title":"Blood."},{"key":"2019111821490364500_B45","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1182\/blood.V82.8.2289.2289","article-title":"p53 mutations are associated with histologic transformation of follicular lymphoma.","volume":"82","author":"Lo Coco","year":"1993","journal-title":"Blood."},{"key":"2019111821490364500_B46","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1182\/blood.V82.7.1994.1994","article-title":"p53 mutation is associated with progression in follicular lymphomas.","volume":"82","author":"Sander","year":"1993","journal-title":"Blood."},{"key":"2019111821490364500_B47","doi-asserted-by":"crossref","first-page":"433","DOI":"10.3109\/10428199309148200","article-title":"Combination of t(14;18) and a Burkitt's type translocation in B-cell malignancies.","volume":"10","author":"Karsan","year":"1993","journal-title":"Leuk Lymphoma."},{"key":"2019111821490364500_B48","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1182\/blood.V80.3.758.758","article-title":"MYC rearrangements in histologically progressed follicular lymphomas.","volume":"80","author":"Yano","year":"1992","journal-title":"Blood."},{"key":"2019111821490364500_B49","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1182\/blood.V82.6.1820.1820","article-title":"bcl-2 gene hypomethylation and high-level expression in B-cell chronic lymphocytic leukemia.","volume":"82","author":"Hanada","year":"1993","journal-title":"Blood."},{"key":"2019111821490364500_B50","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1084\/jem.194.11.1625","article-title":"Gene expression profiling of B cell chronic lymphocytic leukemia reveals a homogeneous phenotype related to memory B cells.","volume":"194","author":"Klein","year":"2001","journal-title":"J Exp Med."},{"key":"2019111821490364500_B51","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1084\/jem.194.11.1639","article-title":"Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia.","volume":"194","author":"Rosenwald","year":"2001","journal-title":"J Exp Med."},{"key":"2019111821490364500_B52","doi-asserted-by":"crossref","first-page":"3379","DOI":"10.1182\/blood.V91.9.3379","article-title":"Expression of apoptosis-regulating proteins in chronic lymphocytic leukemia: correlations with in vitro and in vivo chemoresponses.","volume":"91","author":"Kitada","year":"1998","journal-title":"Blood."},{"key":"2019111821490364500_B53","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/ni0302-221","article-title":"NF-kappaB at the crossroads of life and death.","volume":"3","author":"Karin","year":"2002","journal-title":"Nat Immunol."},{"key":"2019111821490364500_B54","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/376167a0","article-title":"Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B.","volume":"376","author":"Beg","year":"1995","journal-title":"Nature."},{"key":"2019111821490364500_B55","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1182\/blood.V87.1.25.25","article-title":"REL proto-oncogene is frequently amplified in extranodal diffuse large cell lymphoma.","volume":"87","author":"Houldsworth","year":"1996","journal-title":"Blood."},{"key":"2019111821490364500_B56","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1182\/blood.V92.1.234.413k22_234_240","article-title":"Chromosomal and gene amplification in diffuse large B-cell lymphoma.","volume":"92","author":"Rao","year":"1998","journal-title":"Blood."},{"key":"2019111821490364500_B57","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1056\/NEJMoa012914","article-title":"The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma.","volume":"346","author":"Rosenwald","year":"2002","journal-title":"N Engl J Med."},{"key":"2019111821490364500_B58","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1182\/blood.V87.4.1571.bloodjournal8741571","article-title":"Primary mediastinal (thymic) B-cell lymphoma is characterized by gains of chromosomal material including 9p and amplification of the REL gene.","volume":"87","author":"Joos","year":"1996","journal-title":"Blood."},{"key":"2019111821490364500_B59","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1182\/blood.V99.4.1381","article-title":"Classical Hodgkin lymphoma is characterized by recurrent copy number gains of the short arm of chromosome 2.","volume":"99","author":"Joos","year":"2002","journal-title":"Blood."},{"key":"2019111821490364500_B60","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1182\/blood.V99.4.1474","article-title":"Recurrent involvement of the REL and BCL11A loci in classical Hodgkin lymphoma.","volume":"99","author":"Martin-Subero","year":"2002","journal-title":"Blood."},{"key":"2019111821490364500_B61","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/0092-8674(91)90285-7","article-title":"B cell lymphoma-associated chromosomal translocation involves candidate oncogene lyt-10, homologous to NF-kappa B p50.","volume":"67","author":"Neri","year":"1991","journal-title":"Cell."},{"key":"2019111821490364500_B62","doi-asserted-by":"crossref","first-page":"3850","DOI":"10.1182\/blood.V84.11.3850.bloodjournal84113850","article-title":"Heterogeneous chromosomal aberrations generate 3\u2032 truncations of the NFKB2\/lyt-10 gene in lymphoid malignancies.","volume":"84","author":"Migliazza","year":"1994","journal-title":"Blood."},{"key":"2019111821490364500_B63","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/0092-8674(90)90347-H","article-title":"The candidate proto-oncogene bcl-3 is related to genes implicated in cell lineage determination and cell cycle control.","volume":"60","author":"Ohno","year":"1990","journal-title":"Cell."},{"key":"2019111821490364500_B64","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.4049\/jimmunol.164.4.2200","article-title":"Modulation of NF-kappa B activity and apoptosis in chronic lymphocytic leukemia B cells.","volume":"164","author":"Furman","year":"2000","journal-title":"J Immunol."},{"key":"2019111821490364500_B65","doi-asserted-by":"crossref","first-page":"6914","DOI":"10.1093\/emboj\/16.23.6914","article-title":"The c-IAP-1 and c-IAP-2 proteins are direct inhibitors of specific caspases.","volume":"16","author":"Roy","year":"1997","journal-title":"EMBO J."},{"key":"2019111821490364500_B66","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1093\/emboj\/17.8.2215","article-title":"IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases.","volume":"17","author":"Deveraux","year":"1998","journal-title":"EMBO J."},{"key":"2019111821490364500_B67","doi-asserted-by":"crossref","first-page":"26661","DOI":"10.1016\/S0021-9258(19)61427-4","article-title":"The inhibitor of apoptosis, cIAP2, functions as a ubiquitin-protein ligase and promotes in vitro monoubiquitination of caspases 3 and 7.","volume":"275","author":"Huang","year":"2000","journal-title":"J Biol Chem."},{"key":"2019111821490364500_B68","doi-asserted-by":"crossref","first-page":"8662","DOI":"10.1073\/pnas.161506698","article-title":"Ubiquitin-protein ligase activity of X-linked inhibitor of apoptosis protein promotes proteasomal degradation of caspase-3 and enhances its anti-apoptotic effect in Fas-induced cell death.","volume":"98","author":"Suzuki","year":"2001","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2019111821490364500_B69","first-page":"961","article-title":"Identification of paracaspases and metacaspases: two ancient families of caspase-like proteins, one of which plays a key role in MALT lymphoma.","volume":"6","author":"Uren","year":"2000","journal-title":"Mol Cell."},{"key":"2019111821490364500_B70","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000022952","article-title":"The API2\/MALT1 fusion product may lead to germinal center B cell lymphomas by suppression of apoptosis.","volume":"51","author":"Stoffel","year":"2001","journal-title":"Hum Hered."},{"key":"2019111821490364500_B71","doi-asserted-by":"crossref","first-page":"41082","DOI":"10.1074\/jbc.C000726200","article-title":"CARD9 is a novel caspase recruitment domain-containing protein that interacts with BCL10\/CLAP and activates NF-kappa B.","volume":"275","author":"Bertin","year":"2000","journal-title":"J Biol Chem."},{"key":"2019111821490364500_B72","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1083\/jcb.148.6.1131","article-title":"Caspase recruitment domain (CARD)-dependent cytoplasmic filaments mediate bcl10-induced NF-kappaB activation.","volume":"148","author":"Guiet","year":"2000","journal-title":"J Cell Biol."},{"key":"2019111821490364500_B73","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0014-5793(01)02414-0","article-title":"Carma1, a CARD-containing binding partner of Bcl10, induces Bcl10 phosphorylation and NF-kappaB activation.","volume":"496","author":"Gaide","year":"2001","journal-title":"FEBS Lett."},{"key":"2019111821490364500_B74","doi-asserted-by":"crossref","first-page":"19012","DOI":"10.1074\/jbc.M009984200","article-title":"Bcl10 and MALT1, independent targets of chromosomal translocation in malt lymphoma, cooperate in a novel NF-kappa B signaling pathway.","volume":"276","author":"Lucas","year":"2001","journal-title":"J Biol Chem."},{"key":"2019111821490364500_B75","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/S0002-9440(10)64630-5","article-title":"BCL10 expression in normal and neoplastic lymphoid tissue: nuclear localization in MALT lymphoma.","volume":"157","author":"Ye","year":"2000","journal-title":"Am J Pathol."},{"key":"2019111821490364500_B76","first-page":"283","article-title":"Bcl10 expression, rearrangement and mutation in MALT lymphoma: correlation with expression of nuclear factor-kappaB.","volume":"19","author":"Ohshima","year":"2001","journal-title":"Int J Oncol."},{"key":"2019111821490364500_B77","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1182\/blood.V99.4.1398","article-title":"BCL10 mutation does not represent an important pathogenic mechanism in gastric MALT-type lymphoma, and the presence of the API2-MLT fusion is associated with aberrant nuclear BCL10 expression.","volume":"99","author":"Maes","year":"2002","journal-title":"Blood."},{"key":"2019111821490364500_B78","doi-asserted-by":"crossref","first-page":"4266","DOI":"10.1182\/blood.V90.11.4266","article-title":"Mutations in the Fas antigen in patients with multiple myeloma.","volume":"90","author":"Landowski","year":"1997","journal-title":"Blood."},{"key":"2019111821490364500_B79","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1182\/blood.V92.9.3018.421k52_3018_3024","article-title":"Somatic Fas mutations in non-Hodgkin's lymphoma: association with extranodal disease and autoimmunity.","volume":"92","author":"Gronbaek","year":"1998","journal-title":"Blood."},{"key":"2019111821490364500_B80","first-page":"5640","article-title":"Somatic mutations of the CD95 gene in Hodgkin and Reed-Sternberg cells.","volume":"60","author":"Muschen","year":"2000","journal-title":"Cancer Res."},{"key":"2019111821490364500_B81","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1038\/labinvest.3780310","article-title":"Loss of Fas (CD95\/APO-1) regulatory function is an important step in early MALT-type lymphoma development.","volume":"81","author":"Seeberger","year":"2001","journal-title":"Lab Invest."},{"key":"2019111821490364500_B82","first-page":"1382","article-title":"Frequent mutations of Fas gene in thyroid lymphoma.","volume":"61","author":"Takakuwa","year":"2001","journal-title":"Cancer Res."},{"key":"2019111821490364500_B83","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0167-5699(95)80069-7","article-title":"Fas and Fas ligand: lpr and gld mutations.","volume":"16","author":"Nagata","year":"1995","journal-title":"Immunol Today."},{"key":"2019111821490364500_B84","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1182\/blood.V98.1.194","article-title":"The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis.","volume":"98","author":"Straus","year":"2001","journal-title":"Blood."},{"key":"2019111821490364500_B85","first-page":"1227","article-title":"Expression and function of the FAS antigen in B chronic lymphocytic leukemia and hairy cell leukemia.","volume":"9","author":"Panayiotidis","year":"1995","journal-title":"Leukemia."},{"key":"2019111821490364500_B86","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1600-0609.1998.tb01713.x","article-title":"Downregulation of the CD95 receptor and defect CD40-mediated signal transduction in B-chronic lymphocytic leukemia cells.","volume":"61","author":"Laytragoon-Lewin","year":"1998","journal-title":"Eur J Haematol."},{"key":"2019111821490364500_B87","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1046\/j.1365-2141.1998.00958.x","article-title":"Unbalanced expression of Fas and CD40 in mantle cell lymphoma.","volume":"103","author":"Clodi","year":"1998","journal-title":"Br J Haematol."},{"key":"2019111821490364500_B88","doi-asserted-by":"crossref","first-page":"3487","DOI":"10.1002\/j.1460-2075.1994.tb06655.x","article-title":"Cyclin D1\/bcl-1 cooperates with myc genes in the generation of B-cell lymphoma in transgenic mice.","volume":"13","author":"Lovec","year":"1994","journal-title":"EMBO J."},{"key":"2019111821490364500_B89","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1182\/blood.V98.3.787","article-title":"Altered apoptosis pathways in mantle cell lymphoma detected by oligonucleotide microarray.","volume":"98","author":"Hofmann","year":"2001","journal-title":"Blood."},{"key":"2019111821490364500_B90","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1182\/blood.V99.1.238","article-title":"ATM gene inactivation in mantle cell lymphoma mainly occurs by truncating mutations and missense mutations involving the phosphatidylinositol-3 kinase domain and is associated with increasing numbers of chromosomal imbalances.","volume":"99","author":"Camacho","year":"2002","journal-title":"Blood."},{"key":"2019111821490364500_B91","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/S0002-9440(10)65022-5","article-title":"Immunohistochemical analysis of cyclin D1 shows deregulated expression in multiple myeloma with the t(11;14).","volume":"156","author":"Pruneri","year":"2000","journal-title":"Am J Pathol."},{"key":"2019111821490364500_B92","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1111\/j.1365-2141.1995.tb05429.x","article-title":"Increased expression of the PRAD-1\/CCND1 gene in hairy cell leukaemia.","volume":"91","author":"Bosch","year":"1995","journal-title":"Br J Haematol."},{"key":"2019111821490364500_B93","first-page":"4552","article-title":"Deficiency of the ATM protein expression defines an aggressive subgroup of B-cell chronic lymphocytic leukemia.","volume":"58","author":"Starostik","year":"1998","journal-title":"Cancer Res."},{"key":"2019111821490364500_B94","first-page":"24","article-title":"ATM mutations in B-cell chronic lymphocytic leukemia.","volume":"59","author":"Bullrich","year":"1999","journal-title":"Cancer Res."},{"key":"2019111821490364500_B95","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0140-6736(98)10117-4","article-title":"Inactivation of ataxia telangiectasia mutated gene in B-cell chronic lymphocytic leukaemia.","volume":"353","author":"Stankovic","year":"1999","journal-title":"Lancet."},{"key":"2019111821490364500_B96","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1182\/blood.V98.3.814","article-title":"p53 dysfunction in B-cell chronic lymphocytic leukemia: inactivation of ATM as an alternative to TP53 mutation.","volume":"98","author":"Pettitt","year":"2001","journal-title":"Blood."},{"key":"2019111821490364500_B97","first-page":"1296","article-title":"Cell cycle regulatory proteins and apoptosis in B-cell chronic lymphocytic leukemia.","volume":"86","author":"Wolowiec","year":"2001","journal-title":"Haematologica."},{"key":"2019111821490364500_B98","doi-asserted-by":"crossref","first-page":"3452","DOI":"10.1182\/blood.V82.11.3452.3452","article-title":"p53 gene mutation in B-cell chronic lymphocytic leukemia is associated with drug resistance and is independent of MDR1\/MDR3 gene expression.","volume":"82","author":"el Rouby","year":"1993","journal-title":"Blood."},{"key":"2019111821490364500_B99","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1182\/blood-2001-11-0066","article-title":"Relationship between p53 dysfunction, CD38 expression, and IgVH mutation in chronic lymphocytic leukemia.","volume":"100","author":"Lin","year":"2002","journal-title":"Blood."},{"key":"2019111821490364500_B100","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1182\/blood.V94.6.1840","article-title":"Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia.","volume":"94","author":"Damle","year":"1999","journal-title":"Blood."},{"key":"2019111821490364500_B101","doi-asserted-by":"crossref","first-page":"5638","DOI":"10.1002\/j.1460-2075.1995.tb00251.x","article-title":"Loss of p53 function through PAX-mediated transcriptional repression.","volume":"14","author":"Stuart","year":"1995","journal-title":"EMBO J."},{"key":"2019111821490364500_B102","doi-asserted-by":"crossref","first-page":"3865","DOI":"10.1182\/blood.V92.10.3865","article-title":"Deregulated PAX-5 transcription from a translocated IgH promoter in marginal zone lymphoma.","volume":"92","author":"Morrison","year":"1998","journal-title":"Blood."},{"key":"2019111821490364500_B103","doi-asserted-by":"crossref","first-page":"5262","DOI":"10.1073\/pnas.90.11.5262","article-title":"Identification of the gene associated with the recurring chromosomal translocations t(3;14)(q27;q32) and t(3;22)(q27;q11) in B-cell lymphomas.","volume":"90","author":"Baron","year":"1993","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2019111821490364500_B104","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/sj.leu.2400577","article-title":"Expression of LAZ3\/BCL6 in follicular center (FC) B cells of reactive lymph nodes and FC-derived non-Hodgkin lymphomas.","volume":"11","author":"Bajalica-Lagercrantz","year":"1997","journal-title":"Leukemia."},{"key":"2019111821490364500_B105","first-page":"1657","article-title":"The murine BCL6 gene is induced in activated lymphocytes as an immediate early gene.","volume":"11","author":"Fukuda","year":"1995","journal-title":"Oncogene."},{"key":"2019111821490364500_B106","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1182\/blood.V86.1.28.bloodjournal86128","article-title":"BCL-6 gene product, a 92- to 98-kD nuclear phosphoprotein, is highly expressed in germinal center B cells and their neoplastic counterparts.","volume":"86","author":"Onizuka","year":"1995","journal-title":"Blood."},{"key":"2019111821490364500_B107","first-page":"1543","article-title":"Monoclonal antibodies PG-B6a and PG-B6p recognize, respectively, a highly conserved and a formol-resistant epitope on the human BCL-6 protein amino-terminal region.","volume":"148","author":"Flenghi","year":"1996","journal-title":"Am J Pathol."},{"key":"2019111821490364500_B108","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1097\/00000478-200006000-00010","article-title":"CD10 and BCL-6 expression in paraffin sections of normal lymphoid tissue and B-cell lymphomas.","volume":"24","author":"Dogan","year":"2000","journal-title":"Am J Surg Pathol."},{"key":"2019111821490364500_B109","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/ng0697-161","article-title":"The BCL-6 proto-oncogene controls germinal-centre formation and Th2-type inflammation.","volume":"16","author":"Ye","year":"1997","journal-title":"Nat Genet."},{"key":"2019111821490364500_B110","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S1074-7613(00)00020-0","article-title":"BCL-6 represses genes that function in lymphocyte differentiation, inflammation, and cell cycle control.","volume":"13","author":"Shaffer","year":"2000","journal-title":"Immunity."},{"key":"2019111821490364500_B111","first-page":"2017","article-title":"Molecular characterization of primary mediastinal B cell lymphoma.","volume":"148","author":"Tsang","year":"1996","journal-title":"Am J Pathol."},{"key":"2019111821490364500_B112","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1182\/blood-2001-11-0117","article-title":"Immunoglobulin (Ig)\/BCL6 versus non-Ig\/BCL6 gene fusion in diffuse large B-cell lymphoma corresponds to a high- versus low-level expression of BCL6 mRNA.","volume":"99","author":"Ueda","year":"2002","journal-title":"Blood."},{"key":"2019111821490364500_B113","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/S0002-9440(10)62564-3","article-title":"A short mutational hot spot in the first intron of BCL-6 is associated with increased BCL-6 expression and with longer overall survival in large B-cell lymphomas.","volume":"160","author":"Artiga","year":"2002","journal-title":"Am J Pathol."},{"key":"2019111821490364500_B114","first-page":"1495","article-title":"The LAZ3\/BCL6 oncogene encodes a sequence-specific transcriptional inhibitor: a novel function for the BTB\/POZ domain as an autonomous repressing domain.","volume":"6","author":"Deweindt","year":"1995","journal-title":"Cell Growth Differ."},{"key":"2019111821490364500_B115","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/gcc.2870130314","article-title":"BCL6 encodes a sequence-specific DNA-binding protein.","volume":"13","author":"Baron","year":"1995","journal-title":"Genes Chromosomes Cancer."},{"key":"2019111821490364500_B116","first-page":"2331","article-title":"Transcriptional repression by the proto-oncogene BCL-6.","volume":"12","author":"Seyfert","year":"1996","journal-title":"Oncogene."},{"key":"2019111821490364500_B117","doi-asserted-by":"crossref","first-page":"6947","DOI":"10.1073\/pnas.93.14.6947","article-title":"BCL-6, a POZ\/zinc-finger protein, is a sequence-specific transcriptional repressor.","volume":"93","author":"Chang","year":"1996","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2019111821490364500_B118","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0092-8674(94)90321-2","article-title":"Blimp-1, a novel zinc finger-containing protein that can drive the maturation of B lymphocytes into immunoglobulin-secreting cells.","volume":"77","author":"Turner","year":"1994","journal-title":"Cell."},{"key":"2019111821490364500_B119","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1126\/science.276.5312.596","article-title":"Repression of c-myc transcription by Blimp-1, an inducer of terminal B cell differentiation.","volume":"276","author":"Lin","year":"1997","journal-title":"Science."},{"key":"2019111821490364500_B120","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.1073\/pnas.042702599","article-title":"The human programmed cell death-2 (PDCD2) gene is a target of BCL6 repression: implications for a role of BCL6 in the down-regulation of apoptosis.","volume":"99","author":"Baron","year":"2002","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2019111821490364500_B121","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/sj.onc.1202306","article-title":"The proto-oncogene Bc16 inhibits apoptotic cell death in differentiation-induced mouse myogenic cells.","volume":"18","author":"Kumagai","year":"1999","journal-title":"Oncogene."},{"key":"2019111821490364500_B122","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1242\/dev.128.1.57","article-title":"Testicular germ cell apoptosis in Bcl6-deficient mice.","volume":"128","author":"Kojima","year":"2001","journal-title":"Development."},{"key":"2019111821490364500_B123","doi-asserted-by":"crossref","first-page":"14255","DOI":"10.1074\/jbc.M110901200","article-title":"The forkhead transcription factor AFX activates apoptosis by induction of the BCL-6 transcriptional repressor.","volume":"277","author":"Tang","year":"2002","journal-title":"J Biol Chem."},{"key":"2019111821490364500_B124","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1101\/gad.929302","article-title":"A senescence rescue screen identifies BCL6 as an inhibitor of anti-proliferative p19(ARF)-p53 signaling.","volume":"16","author":"Shvarts","year":"2002","journal-title":"Genes Dev."},{"key":"2019111821490364500_B125","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.1182\/blood.V96.8.2907","article-title":"Nonimmunoglobulin (non-Ig)\/BCL6 gene fusion in diffuse large B-cell lymphoma results in worse prognosis than Ig\/BCL6.","volume":"96","author":"Akasaka","year":"2000","journal-title":"Blood."},{"key":"2019111821490364500_B126","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/35000501","article-title":"Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling.","volume":"403","author":"Alizadeh","year":"2000","journal-title":"Nature."},{"key":"2019111821490364500_B127","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1182\/blood.V99.7.2285","article-title":"The t(14;18) defines a unique subset of diffuse large B-cell lymphoma with a germinal center B-cell gene expression profile.","volume":"99","author":"Huang","year":"2002","journal-title":"Blood."},{"key":"2019111821490364500_B128","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1101\/gad928101","article-title":"Deconstructing myc.","volume":"15","author":"Eisenman","year":"2001","journal-title":"Genes Dev."},{"key":"2019111821490364500_B129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/MCB.19.1.1","article-title":"c-Myc target genes involved in cell growth, apoptosis, and metabolism.","volume":"19","author":"Dang","year":"1999","journal-title":"Mol Cell Biol."},{"key":"2019111821490364500_B130","doi-asserted-by":"crossref","first-page":"D250","DOI":"10.2741\/A239","article-title":"Myc and the cell cycle.","volume":"3","author":"Amati","year":"1998","journal-title":"Front Biosci."},{"key":"2019111821490364500_B131","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0092-8674(93)90661-9","article-title":"Mad: a heterodimeric partner for Max that antagonizes Myc transcriptional activity.","volume":"72","author":"Ayer","year":"1993","journal-title":"Cell."},{"key":"2019111821490364500_B132","doi-asserted-by":"crossref","first-page":"5646","DOI":"10.1002\/j.1460-2075.1995.tb00252.x","article-title":"Mad3 and Mad4: novel Max-interacting transcriptional repressors that suppress c-myc dependent transformation and are expressed during neural and epidermal differentiation.","volume":"14","author":"Hurlin","year":"1995","journal-title":"EMBO J."},{"key":"2019111821490364500_B133","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/35070076","article-title":"Repression of p15INK4b expression by Myc through association with Miz-1.","volume":"3","author":"Staller","year":"2001","journal-title":"Nat Cell Biol."},{"key":"2019111821490364500_B134","doi-asserted-by":"crossref","first-page":"3260","DOI":"10.1073\/pnas.97.7.3260","article-title":"Expression analysis with oligonucleotide microarrays reveals that MYC regulates genes involved in growth, cell cycle, signaling, and adhesion.","volume":"97","author":"Coller","year":"2000","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2019111821490364500_B135","doi-asserted-by":"crossref","first-page":"4984","DOI":"10.1038\/sj.onc.1204459","article-title":"A DNA microarray screen for genes involved in c-MYC and N-MYC oncogenesis in human tumors.","volume":"20","author":"Schuldiner","year":"2001","journal-title":"Oncogene."},{"key":"2019111821490364500_B136","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1038\/sj.onc.1204245","article-title":"Repression of transcription of the p27(Kip1) cyclin-dependent kinase inhibitor gene by c-Myc.","volume":"20","author":"Yang","year":"2001","journal-title":"Oncogene."},{"key":"2019111821490364500_B137","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1101\/gad.12.12.1769","article-title":"Myc activates telomerase.","volume":"12","author":"Wang","year":"1998","journal-title":"Genes Dev."},{"key":"2019111821490364500_B138","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1101\/gad.12.15.2424","article-title":"Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization.","volume":"12","author":"Zindy","year":"1998","journal-title":"Genes Dev."},{"key":"2019111821490364500_B139","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1101\/gad.13.20.2658","article-title":"Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis.","volume":"13","author":"Eischen","year":"1999","journal-title":"Genes Dev."},{"key":"2019111821490364500_B140","doi-asserted-by":"crossref","first-page":"5063","DOI":"10.1128\/MCB.21.15.5063-5070.2001","article-title":"Apoptosis triggered by Myc-induced suppression of Bcl-X(L) or Bcl-2 is bypassed during lymphomagenesis.","volume":"21","author":"Eischen","year":"2001","journal-title":"Mol Cell Biol."},{"key":"2019111821490364500_B141","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-230X(08)60476-5","article-title":"Control of c-myc regulation in normal and neoplastic cells.","volume":"56","author":"Spencer","year":"1991","journal-title":"Adv Cancer Res."},{"key":"2019111821490364500_B142","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1101\/gad.836800","article-title":"Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability.","volume":"14","author":"Sears","year":"2000","journal-title":"Genes Dev."},{"key":"2019111821490364500_B143","doi-asserted-by":"crossref","first-page":"3152","DOI":"10.1182\/blood.V92.9.3152.421a07_3152_3162","article-title":"Clinical relevance of BCL2, BCL6, and MYC rearrangements in diffuse large B-cell lymphoma.","volume":"92","author":"Kramer","year":"1998","journal-title":"Blood."},{"key":"2019111821490364500_B144","doi-asserted-by":"crossref","first-page":"7967","DOI":"10.1128\/MCB.14.12.7967","article-title":"NF-kappa B sites function as positive regulators of expression of the translocated c-myc allele in Burkitt's lymphoma.","volume":"14","author":"Ji","year":"1994","journal-title":"Mol Cell Biol."},{"key":"2019111821490364500_B145","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1126\/science.3685977","article-title":"Mutations in the first exon are associated with altered transcription of c-myc in Burkitt lymphoma.","volume":"238","author":"Cesarman","year":"1987","journal-title":"Science."},{"key":"2019111821490364500_B146","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/35085588","article-title":"Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas.","volume":"412","author":"Pasqualucci","year":"2001","journal-title":"Nature."},{"key":"2019111821490364500_B147","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1309\/YHFE-R65B-D3LK-3GGV","article-title":"Expression of c-Myc and p53 correlates with clinical outcome in diffuse large B-cell lymphomas.","volume":"113","author":"Chang","year":"2000","journal-title":"Am J Clin Pathol."},{"key":"2019111821490364500_B148","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/ajh.1084","article-title":"p53, Mdm2, and c-Myc overexpression is associated with a poor prognosis in aggressive non-Hodgkin's lymphomas.","volume":"67","author":"Pagnano","year":"2001","journal-title":"Am J Hematol."},{"key":"2019111821490364500_B149","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1038\/sj.leu.2401599","article-title":"c-myc mRNA expression and genomic alterations in mantle cell lymphomas and other nodal non-Hodgkin's lymphomas.","volume":"13","author":"Hernandez","year":"1999","journal-title":"Leukemia."},{"key":"2019111821490364500_B150","first-page":"3689","article-title":"The Pezcoller lecture: cancer cell cycles revisited.","volume":"60","author":"Sherr","year":"2000","journal-title":"Cancer Res."},{"key":"2019111821490364500_B151","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1002\/path.1711690404","article-title":"Retinoblastoma (Rb) gene product expression in lymphomas: correlation with Ki67 growth fraction.","volume":"169","author":"Martinez","year":"1993","journal-title":"J Pathol."},{"key":"2019111821490364500_B152","first-page":"1591","article-title":"Expression of retinoblastoma gene product (pRb) in mantle cell lymphomas: correlation with cyclin D1 (PRAD1\/CCND1) mRNA levels and proliferative activity.","volume":"148","author":"Jares","year":"1996","journal-title":"Am J Pathol."},{"key":"2019111821490364500_B153","doi-asserted-by":"crossref","first-page":"4949","DOI":"10.1182\/blood.V87.12.4949.bloodjournal87124949","article-title":"Inactivation of multiple tumor-suppressor genes involved in negative regulation of the cell cycle, MTS1\/p16INK4A\/CDKN2, MTS2\/p15INK4B, p53, and Rb genes in primary lymphoid malignancies.","volume":"87","author":"Hangaishi","year":"1996","journal-title":"Blood."},{"key":"2019111821490364500_B154","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1182\/blood.V77.4.833.833","article-title":"Inactivation of the retinoblastoma gene in human lymphoid neoplasms.","volume":"77","author":"Ginsberg","year":"1991","journal-title":"Blood."},{"key":"2019111821490364500_B155","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1054\/bjoc.2000.1435","article-title":"Cell cycle regulators p27 and pRb in lymphomas\u2014correlation with histology and proliferative activity.","volume":"83","author":"Kiviniemi","year":"2000","journal-title":"Br J Cancer."},{"key":"2019111821490364500_B156","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1038\/bjc.1996.489","article-title":"Anomalous retinoblastoma protein expression in Sternberg-Reed cells in Hodgkin's disease: a comparative study with p53 and Ki67 expression.","volume":"74","author":"Sanchez-Beato","year":"1996","journal-title":"Br J Cancer."},{"key":"2019111821490364500_B157","first-page":"97","article-title":"Altered expression of the retinoblastoma gene product in human high grade non-Hodgkin's lymphomas.","volume":"8","author":"Weide","year":"1994","journal-title":"Leukemia."},{"key":"2019111821490364500_B158","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1200\/JCO.1998.16.5.1931","article-title":"Clinical outcome in diffuse large B-cell lymphoma is dependent on the relationship between different cell-cycle regulator proteins.","volume":"16","author":"Sanchez","year":"1998","journal-title":"J Clin Oncol."},{"key":"2019111821490364500_B159","first-page":"2429","article-title":"Adverse clinical outcome in Hodgkin's disease is associated with loss of retinoblastoma protein expression, high Ki67 proliferation index, and absence of Epstein-Barr virus-latent membrane protein 1 expression.","volume":"90","author":"Morente","year":"1997","journal-title":"Blood."},{"key":"2019111821490364500_B160","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1182\/blood.V95.6.1925","article-title":"Deletion of 13q14 remains an independent adverse prognostic variable in multiple myeloma despite its frequent detection by interphase fluorescence in situ hybridization.","volume":"95","author":"Zojer","year":"2000","journal-title":"Blood."},{"key":"2019111821490364500_B161","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S0002-9440(10)64941-3","article-title":"Genetic alterations of the retinoblastoma-related gene RB2\/p130 identify different pathogenetic mechanisms in and among Burkitt's lymphoma subtypes.","volume":"156","author":"Cinti","year":"2000","journal-title":"Am J Pathol."},{"key":"2019111821490364500_B162","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1182\/blood.V94.2.765","article-title":"Anomalous high p27\/KIP1 expression in a subset of aggressive B-cell lymphomas is associated with cyclin D3 overexpression: p27\/KIP1-cyclin D3 colocalization in tumor cells.","volume":"94","author":"Sanchez-Beato","year":"1999","journal-title":"Blood."},{"key":"2019111821490364500_B163","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/(SICI)1096-9896(199806)185:2<159::AID-PATH73>3.0.CO;2-0","article-title":"Cyclin D3 expression in normal, reactive and neoplastic tissues.","volume":"185","author":"Doglioni","year":"1998","journal-title":"J Pathol."},{"key":"2019111821490364500_B164","first-page":"729","article-title":"Cyclin D3 is a predictive and prognostic factor in diffuse large B-cell lymphoma.","volume":"8","author":"Filipits","year":"2002","journal-title":"Clin Cancer Res."},{"key":"2019111821490364500_B165","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1182\/blood.V98.9.2837","article-title":"Cyclin D3 is a target gene of t(6;14)(p21.1;q32.3) of mature B-cell malignancies.","volume":"98","author":"Sonoki","year":"2001","journal-title":"Blood."},{"key":"2019111821490364500_B166","doi-asserted-by":"crossref","first-page":"2870","DOI":"10.1182\/blood.V85.10.2870.bloodjournal85102870","article-title":"Overexpression of cyclin D2 in chronic B-cell malignancies.","volume":"85","author":"Delmer","year":"1995","journal-title":"Blood."},{"key":"2019111821490364500_B167","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.1182\/blood.V90.8.3154","article-title":"Cyclin D1 expression in mantle cell lymphoma is accompanied by downregulation of cyclin D3 and is not related to the proliferative activity.","volume":"90","author":"Ott","year":"1997","journal-title":"Blood."},{"key":"2019111821490364500_B168","doi-asserted-by":"crossref","first-page":"6271","DOI":"10.1038\/sj.onc.1203033","article-title":"Dysregulation of cyclin dependent kinase 6 expression in splenic marginal zone lymphoma through chromosome 7q translocations.","volume":"18","author":"Corcoran","year":"1999","journal-title":"Oncogene."},{"key":"2019111821490364500_B169","first-page":"356","article-title":"Absence of p18 mutations or deletions in lymphoid malignancies.","volume":"10","author":"Otsuki","year":"1996","journal-title":"Leukemia."},{"key":"2019111821490364500_B170","first-page":"1897","article-title":"Alterations of the cyclin-dependent kinase inhibitor p19 (INK4D) is rare in hematopoietic malignancies.","volume":"10","author":"Shiohara","year":"1996","journal-title":"Leukemia."},{"key":"2019111821490364500_B171","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/S0002-9440(10)65630-1","article-title":"Loss of p16\/INK4A protein expression in non-Hodgkin's lymphomas is a frequent finding associated with tumor progression.","volume":"153","author":"Villuendas","year":"1998","journal-title":"Am J Pathol."},{"key":"2019111821490364500_B172","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1182\/blood.V94.5.1773.417a12_1773_1781","article-title":"Frequent methylation silencing of p15(INK4b) (MTS2) and p16(INK4a) (MTS1) in B-cell and T-cell lymphomas.","volume":"94","author":"Baur","year":"1999","journal-title":"Blood."},{"key":"2019111821490364500_B173","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1182\/blood.V91.8.2977.2977_2977_2984","article-title":"p16(INK4a) gene inactivation by deletions, mutations, and hypermethylation is associated with transformed and aggressive variants of non-Hodgkin's lymphomas.","volume":"91","author":"Pinyol","year":"1998","journal-title":"Blood."},{"key":"2019111821490364500_B174","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1182\/blood.V89.1.272","article-title":"Deletions and loss of expression of p16INK4a and p21Waf1 genes are associated with aggressive variants of mantle cell lymphomas.","volume":"89","author":"Pinyol","year":"1997","journal-title":"Blood."},{"key":"2019111821490364500_B175","first-page":"4608","article-title":"Alterations of the cyclin D1\/p16-pRB pathway in mantle cell lymphoma.","volume":"57","author":"Dreyling","year":"1997","journal-title":"Cancer Res."},{"key":"2019111821490364500_B176","first-page":"1240","article-title":"Alterations of cyclin-dependent kinase 4 inhibitor (p16INK4A\/MTS1) gene structure and expression in acute lymphoblastic leukemias.","volume":"9","author":"Delmer","year":"1995","journal-title":"Leukemia."},{"key":"2019111821490364500_B177","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1182\/blood.V86.1.311.bloodjournal861311","article-title":"p16INK4A and p15INK4B gene deletions in primary leukemias.","volume":"86","author":"Haidar","year":"1995","journal-title":"Blood."},{"key":"2019111821490364500_B178","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0002-9440(10)61686-0","article-title":"Overall survival in aggressive B-cell lymphomas is dependent on the accumulation of alterations in p53, p16, and p27.","volume":"159","author":"Sanchez-Beato","year":"2001","journal-title":"Am J Pathol."},{"key":"2019111821490364500_B179","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.1182\/blood.V86.8.2900.2900","article-title":"Deletion of cyclin-dependent kinase 4 inhibitor genes P15 and P16 in non-Hodgkin' lymphoma.","volume":"86","author":"Koduru","year":"1995","journal-title":"Blood."},{"key":"2019111821490364500_B180","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/sj.leu.2401315","article-title":"Aberrations of the p53 pathway components p53, MDM2 and CDKN2A appear independent in diffuse large B cell lymphoma.","volume":"13","author":"Moller","year":"1999","journal-title":"Leukemia."},{"key":"2019111821490364500_B181","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1182\/blood.V91.5.1680","article-title":"p16\/INK4a and p15\/INK4b gene methylation and absence of p16\/INK4a mRNA and protein expression in Burkitt's lymphoma.","volume":"91","author":"Klangby","year":"1998","journal-title":"Blood."},{"key":"2019111821490364500_B182","first-page":"1453","article-title":"Loss of p16 protein expression associated with methylation of the p16INK4A gene is a frequent finding in Hodgkin's disease.","volume":"79","author":"Garcia","year":"1999","journal-title":"Lab Invest."},{"key":"2019111821490364500_B183","doi-asserted-by":"crossref","first-page":"2724","DOI":"10.1182\/blood.V86.7.2724.2724","article-title":"Mutational analysis of the CDKN2 (MTS1\/p16ink4A) gene in primary B-cell lymphomas.","volume":"86","author":"Uchida","year":"1995","journal-title":"Blood."},{"key":"2019111821490364500_B184","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1182\/blood.V86.4.1548.bloodjournal8641548","article-title":"Loss of the cyclin-dependent kinase 4-inhibitor (p16; MTS1) gene is frequent in and highly specific to lymphoid tumors in primary human hematopoietic malignancies.","volume":"86","author":"Ogawa","year":"1995","journal-title":"Blood."},{"key":"2019111821490364500_B185","first-page":"837","article-title":"Distinct patterns of inactivation of p15INK4B and p16INK4A characterize the major types of hematological malignancies.","volume":"57","author":"Herman","year":"1997","journal-title":"Cancer Res."},{"key":"2019111821490364500_B186","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1016\/S0002-9440(10)65071-7","article-title":"INK4a\/ARF locus alterations in human non-Hodgkin's lymphomas mainly occur in tumors with wild-type p53 gene.","volume":"156","author":"Pinyol","year":"2000","journal-title":"Am J Pathol."},{"key":"2019111821490364500_B187","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1056\/NEJM199708213370804","article-title":"Mutations of the p53 gene as a prognostic factor in aggressive B-cell lymphoma.","volume":"337","author":"Ichikawa","year":"1997","journal-title":"N Engl J Med."},{"key":"2019111821490364500_B188","doi-asserted-by":"crossref","first-page":"4078","DOI":"10.1182\/blood.V90.10.4078","article-title":"Correlation between mutation in P53, p53 expression, cytogenetics, histologic type, and survival in patients with B-cell non-Hodgkin's lymphoma.","volume":"90","author":"Koduru","year":"1997","journal-title":"Blood."},{"key":"2019111821490364500_B189","first-page":"1085","article-title":"Disrupted p53 function as predictor of treatment failure and poor prognosis in B- and T-cell non-Hodgkin's lymphoma.","volume":"5","author":"Moller","year":"1999","journal-title":"Clin Cancer Res."},{"key":"2019111821490364500_B190","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1182\/blood.V82.10.3151.3151","article-title":"The expression of p53 protein in non-Hodgkin's lymphomas is not always dependent on p53 gene mutations.","volume":"82","author":"Villuendas","year":"1993","journal-title":"Blood."},{"key":"2019111821490364500_B191","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1182\/blood.V89.2.601","article-title":"Relationship of p53, bcl-2, and tumor proliferation to clinical drug resistance in non-Hodgkin's lymphomas.","volume":"89","author":"Wilson","year":"1997","journal-title":"Blood."},{"key":"2019111821490364500_B192","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/(SICI)1096-9896(199701)181:1<51::AID-PATH689>3.0.CO;2-N","article-title":"p21WAF1\/CIP1 and MDM2 expression in non-Hodgkin's lymphoma and their relationship to p53 status: a p53+, MDM2-, p21-immunophenotype associated with missense p53 mutations.","volume":"181","author":"Villuendas","year":"1997","journal-title":"J Pathol."},{"key":"2019111821490364500_B193","doi-asserted-by":"crossref","first-page":"4587","DOI":"10.1182\/blood.V86.12.4587.bloodjournal86124587","article-title":"The accumulation of p53 abnormalities is associated with progression of mucosa-associated lymphoid tissue lymphoma.","volume":"86","author":"Du","year":"1995","journal-title":"Blood."},{"key":"2019111821490364500_B194","doi-asserted-by":"crossref","first-page":"4302","DOI":"10.1182\/blood.V87.10.4302.bloodjournal87104302","article-title":"p53 mutations in mantle cell lymphoma are associated with variant cytology and predict a poor prognosis.","volume":"87","author":"Greiner","year":"1996","journal-title":"Blood."},{"key":"2019111821490364500_B195","doi-asserted-by":"crossref","first-page":"3351","DOI":"10.1182\/blood.V87.8.3351.bloodjournal8783351","article-title":"p53 gene mutations and protein overexpression are associated with aggressive variants of mantle cell lymphomas.","volume":"87","author":"Hernandez","year":"1996","journal-title":"Blood."},{"key":"2019111821490364500_B196","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/sj.leu.2401721","article-title":"p53 mutations in hairy cell leukemia.","volume":"14","author":"Konig","year":"2000","journal-title":"Leukemia."},{"key":"2019111821490364500_B197","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1200\/JCO.1995.13.4.812","article-title":"Clinical significance of p53 mutations in newly diagnosed Burkitt's lymphoma and acute lymphoblastic leukemia: a report of 48 cases.","volume":"13","author":"Preudhomme","year":"1995","journal-title":"J Clin Oncol."},{"key":"2019111821490364500_B198","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1182\/blood.V94.5.1755.417a26_1755_1760","article-title":"Mutation of the p53 gene is not a typical feature of Hodgkin and Reed-Sternberg cells in Hodgkin's disease.","volume":"94","author":"Montesinos-Rongen","year":"1999","journal-title":"Blood."},{"key":"2019111821490364500_B199","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1046\/j.1365-2141.2001.02566.x","article-title":"MDM2 gene amplification and lack of p53 point mutations in Hodgkin and Reed-Sternberg cells: results from single-cell polymerase chain reaction and molecular cytogenetic studies.","volume":"112","author":"Kupper","year":"2001","journal-title":"Br J Haematol."},{"key":"2019111821490364500_B200","first-page":"519","article-title":"p53 mutations in Hodgkin's disease.","volume":"75","author":"Chen","year":"1996","journal-title":"Lab Invest."},{"key":"2019111821490364500_B201","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/35106009","article-title":"Assessing TP53 status in human tumours to evaluate clinical outcome.","volume":"1","author":"Soussi","year":"2001","journal-title":"Nat Rev Cancer."},{"key":"2019111821490364500_B202","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/path.1711660305","article-title":"P53 protein expression in lymphomas and reactive lymphoid tissue.","volume":"166","author":"Villuendas","year":"1992","journal-title":"J Pathol."},{"key":"2019111821490364500_B203","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.1182\/blood.V81.11.3097.3097","article-title":"Single-cell analysis of Hodgkin and Reed-Sternberg cells: molecular heterogeneity of gene expression and p53 mutations.","volume":"81","author":"Trumper","year":"1993","journal-title":"Blood."},{"key":"2019111821490364500_B204","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1073\/pnas.90.7.2817","article-title":"Mutation of p53 in primary biopsy material and cell lines from Hodgkin disease.","volume":"90","author":"Gupta","year":"1993","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2019111821490364500_B205","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/(SICI)1096-9896(199609)180:1<58::AID-PATH610>3.0.CO;2-W","article-title":"MDM2 and p21WAF1\/CIP1, wild-type p53-induced proteins, are regularly expressed by Sternberg-Reed cells in Hodgkin's disease.","volume":"180","author":"Sanchez-Beato","year":"1996","journal-title":"J Pathol."},{"key":"2019111821490364500_B206","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/bjc.1994.61","article-title":"p53 and bcl-2 expression in high-grade B-cell lymphomas: correlation with survival time.","volume":"69","author":"Piris","year":"1994","journal-title":"Br J Cancer."},{"key":"2019111821490364500_B207","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1182\/blood.V99.7.2291","article-title":"5\u2032 CpG island hypermethylation is associated with transcriptional silencing of the p21(CIP1\/WAF1\/SDI1) gene and confers poor prognosis in acute lymphoblastic leukemia.","volume":"99","author":"Roman-Gomez","year":"2002","journal-title":"Blood."},{"key":"2019111821490364500_B208","doi-asserted-by":"crossref","first-page":"4295","DOI":"10.1182\/blood.V84.12.4295.bloodjournal84124295","article-title":"Abnormal expression of the p53-binding protein MDM2 in Hodgkin's disease.","volume":"84","author":"Chilosi","year":"1994","journal-title":"Blood."},{"key":"2019111821490364500_B209","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1182\/blood.V82.9.2617.2617","article-title":"The human MDM-2 oncogene is overexpressed in leukemias.","volume":"82","author":"Bueso-Ramos","year":"1993","journal-title":"Blood."},{"key":"2019111821490364500_B210","first-page":"1010","article-title":"Oncoprotein MDM2 overexpression is associated with poor prognosis in distinct non-Hodgkin's lymphoma entities.","volume":"12","author":"Moller","year":"1999","journal-title":"Mod Pathol."},{"key":"2019111821490364500_B211","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.1182\/blood.V84.9.3158.3158","article-title":"The MDM2 oncogene overexpression in chronic lymphocytic leukemia and low-grade lymphoma of B-cell origin.","volume":"84","author":"Watanabe","year":"1994","journal-title":"Blood."},{"key":"2019111821490364500_B212","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/sj.leu.2401619","article-title":"Incidence and prognostic significance of MDM2 oncoprotein overexpression in relapsed childhood acute lymphoblastic leukemia.","volume":"14","author":"Zhou","year":"2000","journal-title":"Leukemia."},{"key":"2019111821490364500_B213","doi-asserted-by":"crossref","first-page":"3453","DOI":"10.1093\/nar\/26.15.3453","article-title":"The MDM2 gene amplification database.","volume":"26","author":"Momand","year":"1998","journal-title":"Nucleic Acids Res."},{"key":"2019111821490364500_B214","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1182\/blood.V99.4.1411","article-title":"p14(ARF) nuclear overexpression in aggressive B-cell lymphomas is a sensor of malfunction of the common tumor suppressor pathways.","volume":"99","author":"Sanchez-Aguilera","year":"2002","journal-title":"Blood."},{"key":"2019111821490364500_B215","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0002-9440(10)65277-7","article-title":"p27kip1: a multifunctional cyclin-dependent kinase inhibitor with prognostic significance in human cancers.","volume":"154","author":"Lloyd","year":"1999","journal-title":"Am J Pathol."},{"key":"2019111821490364500_B216","first-page":"2266","article-title":"Molecular analysis of the cyclin-dependent kinase inhibitor gene p27\/Kip1 in human malignancies.","volume":"55","author":"Kawamata","year":"1995","journal-title":"Cancer Res."},{"key":"2019111821490364500_B217","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1182\/blood.V86.5.1924.bloodjournal8651924","article-title":"Alterations of the p27KIP1 gene in non-Hodgkin's lymphomas and adult T-cell leukemia\/lymphoma.","volume":"86","author":"Morosetti","year":"1995","journal-title":"Blood."},{"key":"2019111821490364500_B218","first-page":"1211","article-title":"p27Kip1: chromosomal mapping to 12p12\u201412p13.1 and absence of mutations in human tumors.","volume":"55","author":"Ponce-Castaneda","year":"1995","journal-title":"Cancer Res."},{"key":"2019111821490364500_B219","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0002-9440(10)65558-7","article-title":"Mantle cell lymphomas lack expression of p27Kip1, a cyclin-dependent kinase inhibitor.","volume":"153","author":"Quintanilla-Martinez","year":"1998","journal-title":"Am J Pathol."},{"key":"2019111821490364500_B220","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/24179","article-title":"The murine gene p27Kip1 is haplo-insufficient for tumour suppression.","volume":"396","author":"Fero","year":"1998","journal-title":"Nature."},{"key":"2019111821490364500_B221","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1182\/blood.V87.1.324.324","article-title":"Molecular characterization of 12p abnormalities in hematologic malignancies: deletion of KIP1, rearrangement of TEL, and amplification of CCND2.","volume":"87","author":"Hoglund","year":"1996","journal-title":"Blood."},{"key":"2019111821490364500_B222","first-page":"151","article-title":"Cyclin-dependent kinase inhibitor p27KIP1 in lymphoid tissue: p27KIP1 expression is inversely proportional to the proliferative index.","volume":"151","author":"Sanchez-Beato","year":"1997","journal-title":"Am J Pathol."},{"key":"2019111821490364500_B223","doi-asserted-by":"crossref","first-page":"6388","DOI":"10.1038\/sj.onc.1203162","article-title":"Antiproliferative function of p27kip1 is frequently inhibited in highly malignant Burkitt's lymphoma cells.","volume":"18","author":"Barnouin","year":"1999","journal-title":"Oncogene."},{"key":"2019111821490364500_B224","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1182\/blood.V92.3.770","article-title":"Expression of cyclin E and the cyclin-dependent kinase inhibitor p27 in malignant lymphomas: prognostic implications.","volume":"92","author":"Erlanson","year":"1998","journal-title":"Blood."},{"key":"2019111821490364500_B225","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1046\/j.1365-2141.2000.02210.x","article-title":"Low expression of p27 and low proliferation index do not correlate in hairy cell leukaemia.","volume":"111","author":"Chilosi","year":"2000","journal-title":"Br J Haematol."},{"key":"2019111821490364500_B226","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1182\/blood.V95.2.619","article-title":"Increased proteasome degradation of cyclin-dependent kinase inhibitor p27 is associated with a decreased overall survival in mantle cell lymphoma.","volume":"95","author":"Chiarle","year":"2000","journal-title":"Blood."},{"key":"2019111821490364500_B227","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/S0002-9440(10)62571-0","article-title":"S-phase kinase-associated protein 2 expression in non-Hodgkin's lymphoma inversely correlates with p27 expression and defines cells in S phase.","volume":"160","author":"Chiarle","year":"2002","journal-title":"Am J Pathol."},{"key":"2019111821490364500_B228","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1038\/sj.bjc.6690539","article-title":"p27KIP1 is abnormally expressed in diffuse large b-cell lymphomas and is associated with an adverse clinical outcome.","volume":"80","author":"Saez","year":"1999","journal-title":"Br J Cancer."},{"key":"2019111821490364500_B229","doi-asserted-by":"crossref","first-page":"4694","DOI":"10.1182\/blood.V91.12.4694","article-title":"Prognostic significance of the cell cycle inhibitor p27Kip1 in chronic B-cell lymphocytic leukemia.","volume":"91","author":"Vrhovac","year":"1998","journal-title":"Blood."},{"key":"2019111821490364500_B230","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1038\/sj.leu.2401901","article-title":"Concurrent disruption of p16INK4a and the ARF-p53 pathway predicts poor prognosis in aggressive non-Hodgkin's lymphoma.","volume":"14","author":"Gronbaek","year":"2000","journal-title":"Leukemia."}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/101\/4\/1220\/1262923\/h80403001220.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/101\/4\/1220\/1262923\/h80403001220.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,27]],"date-time":"2021-05-27T22:38:11Z","timestamp":1622155091000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/101\/4\/1220\/105938\/Cell-cycle-deregulation-in-Bcell-lymphomas"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,2,15]]},"references-count":230,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2003,2,15]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2002-07-2009","relation":{},"ISSN":["1528-0020","0006-4971"],"issn-type":[{"value":"1528-0020","type":"electronic"},{"value":"0006-4971","type":"print"}],"subject":[],"published":{"date-parts":[[2003,2,15]]}}}